Literature DB >> 17406479

DNA methylation: bisulphite modification and analysis.

Susan J Clark1, Aaron Statham, Clare Stirzaker, Peter L Molloy, Marianne Frommer.   

Abstract

DNA methylation is an important epigenetic modification of DNA in mammalian genomes. DNA methylation patterns are established early in development, modulated during tissue-specific differentiation and disrupted in many disease states, including cancer. To understand further the biological functions of these changes, accurate and reproducible methods are required to fully analyze the DNA methylation sequence. Here, we describe the 'gold-standard' bisulphite conversion protocol that can be used to re-sequence DNA from mammalian cells in order to determine and quantify the methylation state of a gene or genomic region at single-nucleotide resolution. The process of bisulphite treatment exploits the different sensitivities of cytosine and 5-methylcytosine (5-MeC) to deamination by bisulphite under acidic conditions--in which cytosine undergoes conversion to uracil, whereas 5-MeC remains unreactive. Bisulphite conversion of DNA, in either single tubes or in a 96-well format, can be performed in a minimum of 8 h and a maximum of 18 h, depending on the amount and quality of starting DNA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17406479     DOI: 10.1038/nprot.2006.324

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  127 in total

1.  Downregulation of Gadd45beta expression by hepatitis C virus leads to defective cell cycle arrest.

Authors:  Martin R Higgs; Hervé Lerat; Jean-Michel Pawlotsky
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

Review 2.  Using DNA methylation to understand biological consequences of genetic variability.

Authors:  Dena G Hernandez; Andrew B Singleton
Journal:  Neurodegener Dis       Date:  2011-11-26       Impact factor: 2.977

3.  Accurate genome-scale percentage DNA methylation estimates from microarray data.

Authors:  Martin J Aryee; Zhijin Wu; Christine Ladd-Acosta; Brian Herb; Andrew P Feinberg; Srinivasan Yegnasubramanian; Rafael A Irizarry
Journal:  Biostatistics       Date:  2010-09-21       Impact factor: 5.899

Review 4.  Proteomic investigation of epigenetics in neuropsychiatric disorders: a missing link between genetics and behavior?

Authors:  Mariana D Plazas-Mayorca; Kent E Vrana
Journal:  J Proteome Res       Date:  2010-09-09       Impact factor: 4.466

Review 5.  Modern approaches for investigating epigenetic signaling pathways.

Authors:  Adam G Evertts; Barry M Zee; Benjamin A Garcia
Journal:  J Appl Physiol (1985)       Date:  2010-01-28

6.  Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver.

Authors:  Alayne L Brunner; David S Johnson; Si Wan Kim; Anton Valouev; Timothy E Reddy; Norma F Neff; Elizabeth Anton; Catherine Medina; Loan Nguyen; Eric Chiao; Chuba B Oyolu; Gary P Schroth; Devin M Absher; Julie C Baker; Richard M Myers
Journal:  Genome Res       Date:  2009-03-09       Impact factor: 9.043

Review 7.  Epigenetics of progression of chronic kidney disease: fact or fantasy?

Authors:  Maria R Wing; Ali Ramezani; Harindarpal S Gill; Joseph M Devaney; Dominic S Raj
Journal:  Semin Nephrol       Date:  2013-07       Impact factor: 5.299

8.  Epigenetic Basis for the Differentiation Potential of Mesenchymal and Embryonic Stem Cells.

Authors:  Philippe Collas; Agate Noer; Anita L Sørensen
Journal:  Transfus Med Hemother       Date:  2008-05-08       Impact factor: 3.747

9.  Bisulfite-based epityping on pooled genomic DNA provides an accurate estimate of average group DNA methylation.

Authors:  Sophia J Docherty; Oliver S P Davis; Claire M A Haworth; Robert Plomin; Jonathan Mill
Journal:  Epigenetics Chromatin       Date:  2009-03-10       Impact factor: 4.954

10.  Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival.

Authors:  C A Barton; B S Gloss; W Qu; A L Statham; N F Hacker; R L Sutherland; S J Clark; P M O'Brien
Journal:  Br J Cancer       Date:  2009-11-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.